Encompass Health Corporation Common Stock EHC
$137.54
-2.64%
at last close
Analyst Consensus
- Consensus Rating
- Buy (5 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $154.40
- Implied Upside
- +12.3%
- Price Target Range
- $150.00 – $165.00
- Analysts (12 mo)
- 5
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-30 | UBSA.J. Rice |
Maintains | Buy | $155 → $165 |
| 2026-10-30 | TD CowenRyan Langston |
Maintains | Buy | $140 → $150 |
| 2026-10-30 | Truist SecuritiesDavid Macdonald |
Reiterates | Buy | $150 → $156 |
| 2026-10-30 | KeybancMatthew Gillmor |
Maintains | Overweight | $147 → $150 |
| 2026-10-29 | BarclaysAndrew Mok |
Maintains | Overweight | $144 → $151 |
| 2026-08-10 | TD CowenRyan Langston |
Maintains | Buy | $125 → $140 |
| 2026-08-07 | UBSA.J. Rice |
Maintains | Buy | $150 → $155 |
| 2026-08-07 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $140 → $150 |
| 2026-08-06 | BarclaysAndrew Mok |
Maintains | Overweight | $140 → $144 |
| 2026-05-28 | TD CowenRyan Langston |
Initiates coverage on | Buy | $125 |
| 2026-05-05 | BarclaysAndrew Mok |
Maintains | Overweight | $153 → $140 |
| 2026-02-06 | BarclaysAndrew Mok |
Maintains | Overweight | $150 → $153 |
| 2025-10-30 | BarclaysAndrew Mok |
Maintains | Overweight | $141 → $150 |
| 2025-10-02 | UBSA.J. Rice |
Maintains | Buy | $140 → $150 |
| 2025-09-16 | KeybancMatthew Gillmor |
Maintains | Overweight | $135 → $140 |
| 2025-09-10 | B of A SecuritiesKevin Fischbeck |
Maintains | Buy | $145 → $160 |
| 2025-08-14 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $135 → $140 |
| 2025-08-06 | UBSAndrew Mok |
Maintains | Buy | $130 → $140 |
| 2025-06-05 | Stephens & Co.Raj Kumar |
Reiterates | Overweight | $135 |
| 2025-05-27 | KeybancPaul Knight |
Maintains | Overweight | $122 → $135 |
| 2025-04-28 | UBSAndrew Mok |
Maintains | Buy | $117 → $130 |
| 2025-04-28 | RBC CapitalBen Hendrix |
Maintains | Outperform | $110 → $125 |
| 2025-04-28 | Truist SecuritiesDavid Macdonald |
Reiterates | Buy | $116 → $135 |
| 2025-04-25 | KeybancMatthew Gillmor |
Maintains | Overweight | $120 → $122 |
| 2025-04-25 | BarclaysAndrew Mok |
Maintains | Overweight | $118 → $129 |
| 2025-02-11 | RBC CapitalBen Hendrix |
Reiterates | Outperform | $110 |
| 2025-02-10 | KeybancMatthew Gillmor |
Maintains | Overweight | $117 → $120 |
| 2025-02-07 | BarclaysAndrew Mok |
Maintains | Overweight | $116 → $118 |
| 2024-10-30 | RBC CapitalBen Hendrix |
Maintains | Outperform | $105 → $110 |
| 2024-10-30 | Truist SecuritiesDavid Macdonald |
Reiterates | Buy | $108 → $116 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $137.54
- Market Cap
- $13.50 billion
- 52-Week Range
- $92.77 – $143.36
- Average Volume
- 1.15 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.